首页 | 本学科首页   官方微博 | 高级检索  
检索        

微生态制剂的发展现状及其对肝硬化并发症的作用
引用本文:原庆,王惠吉.微生态制剂的发展现状及其对肝硬化并发症的作用[J].中国新药杂志,2004,13(11):977-980.
作者姓名:原庆  王惠吉
作者单位:1. 首都医科大学附属北京友谊医院,消化内科,北京,100050
2. 首都医科大学附属北京友谊医院,综合科,北京,100050
摘    要:微生态制剂在肝硬化患者的一些并发症治疗方面有显著的疗效.现综述近年来新出现的3类微生态制剂及其作用机制,着重讨论了肝硬化患者由于肠道微生态失衡而出现的一些并发症如:腹泻、肝性脑病、腹水并发腹膜炎、内毒素血症等的治疗效果.

关 键 词:微生态制剂  肝硬化  并发症
文章编号:1003-3734(2004)11-0977-04

Situation in the development of microecologics and their therapeutic effects in treatment of complicated cirrhosis
YUAN Qing,WANG Hui-ji.Situation in the development of microecologics and their therapeutic effects in treatment of complicated cirrhosis[J].Chinese Journal of New Drugs,2004,13(11):977-980.
Authors:YUAN Qing  WANG Hui-ji
Abstract:Microecologics are a group of newly emerged agents with significant efficacy in treatment of complicated cirrhosis. In this article, the mechanism and the efficacy of three classes mi-croecologics in treatment of cirrhosis with some complicated symptoms, such as diarrhea, hepatic en-cephalopathy,peritoneal fluid complicated with peritonitis,and endotoxemia are reviewed.
Keywords:microecologics  cirrhosis  complications
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号